{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:38:06Z","timestamp":1788781086910,"version":"build-2803163510"},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.1253\/circj.cj-25-0115","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T18:07:33Z","timestamp":1749751653000},"page":"109-117","source":"Crossref","is-referenced-by-count":5,"title":["Real-World Patent Foramen Ovale Closure in Japan\u3000\u2015 Results From 1-Year Follow-up of the Amplatzer<sup>TM<\/sup> PFO Occluder Japan Post-Marketing Surveillance Study \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Teiji","family":"Akagi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kanazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"},{"name":"Department of Cardiology, Tokyo Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigefumi","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Stroke Center, Saiseikai Kumamoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Iwama","sequence":"additional","affiliation":[{"name":"Gifu Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, International University of Health and Welfare Narita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Stroke and Cerebrovascular Medicine, Kyorin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Saiseikai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, NHO Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PFO Japan PMS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med<\/i> 2017; 377: 1022\u20131032.","DOI":"10.1056\/NEJMoa1610057"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, et al. Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial. J Am Coll Cardiol<\/i> 2018; 71: 2335\u20132342.","DOI":"10.1016\/j.jacc.2018.02.046"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akagi T, Hara H, Kanazawa H, Fukui S, Hashimoto Y, Iguchi Y, et al. Real-world patent foramen ovale (PFO) closure in Japan: 30-day clinical outcomes from the AmplatzerTM<\/sup> PFO Occluder Japan Post-Marketing Surveillance Study. Circ J<\/i> 2024; 88: 1391\u20131397.","DOI":"10.1253\/circj.CJ-24-0080"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke. JAMA<\/i> 2021; 22: 2277\u20132286.","DOI":"10.1001\/jama.2021.20956"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology<\/i> 2013; 81: 619\u2013625.","DOI":"10.1212\/WNL.0b013e3182a08d59"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kavinsky CJ, Szerlip M, Goldsweig AM, Amin Z, Boudoulas KD, Carroll JD, et al. SCAI guidelines for the management of patent foramen ovale. J Soc Cardiovasc Angiogr Interv<\/i> 2022; 1: 100039.","DOI":"10.1016\/j.jscai.2022.100039"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Messe SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, et al. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention. Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology<\/i> 2020; 94: 876\u2013885.","DOI":"10.1212\/WNL.0000000000009443"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakayama R, Takaya Y, Akagi T, Takemoto R, Haruna M, Nakashima M, et al. Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure. Cardiovasc Interv Ther<\/i> 2024; 39: 200\u2013206.","DOI":"10.1007\/s12928-023-00979-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Deng W, Yin S, McMullin D, Inglessis-Azuaje I, Hung J, Lo EH, et al. Residual shunt after patent foramen ovale closure and long term stroke recurrence: A prospective cohort study. Ann Intern Med<\/i> 2020; 172: 717\u2013725.","DOI":"10.7326\/M19-3583"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vukadinovic D, Scheller B, Ukena C, Ewen S, Mahfoud F, Bohm M. Device related risk of atrial fibrillation after closure of patent foramen ovale: A systematic review and meta analysis. Clin Res Cardiol<\/i> 2022; 111: 583\u2013587.","DOI":"10.1007\/s00392-021-01964-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Reddy SA, Peverelli M, MacCarthy T, Vibhishanan J, Agarwal S, Duehmke R, et al. Influence of device choice on atrial arrhythmia incidence following percutaneous patent foramen ovale closure. JACC Cardiovasc Interv<\/i> 2024; 17: 2320\u20132321.","DOI":"10.1016\/j.jcin.2024.07.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ravellette KS, Gornbein J, Tobis JM. Incidence of atrial fibrillation or arrhythmias after patent foramen ovale closure. J Soc Cardiovasc Angiogr Interv<\/i> 2023; 3: 101173.","DOI":"10.1016\/j.jscai.2023.101173"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Apostolos A, Tsiachris D, Drakopoulou M, Trantalis G, Oikonomou G, Ktenopoulos N, et al. Atrial fibrillation after patent foramen ovale closure: Incidence, pathophysiology, and management. J Am Heart Assoc<\/i> 2024; 13: e034249.","DOI":"10.1161\/JAHA.124.034249"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Skibsted CV, Korsholm K, Pedersen L, Bonnesen K, Nielsen-Kudsk JE, Schmidt M. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: A nationwide Danish study. Eur Heart J<\/i> 2023; 44: 3469\u20133477.","DOI":"10.1093\/eurheartj\/ehad305"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chen JZ, Thijs VN. Atrial fibrillation following patent foramen ovale closure. Stroke<\/i> 2021; 52: 1653\u20131661.","DOI":"10.1161\/STROKEAHA.120.030293"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Krishnamurthy Y, Ben-Ami J, Robbins BT, Sommer RJ. Incidence and time course of atrial fibrillation following patent foramen ovale closure. Catheter Cardiovasc Interv<\/i> 2022; 100: 219\u2013224.","DOI":"10.1002\/ccd.30247"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakashima M, Takaya Y, Nakayama R, Tsuji M, Akagi T, Miki T, et al. Morphological features of patent foramen ovale compared between older and young patients with cryptogenic ischemic stroke. Circ J<\/i> 2024; 88: 1398\u20131405.","DOI":"10.1253\/circj.CJ-24-0313"},{"key":"18","unstructured":"18. Iguchi Y, Iwama T, Oki K, Kataoka H, Kawano H, Yamagami H, et al. Guidance on percutaneous closure of patent foramen ovale (PFO) in cryptogenic stroke patients. The Japan Stroke Society, The Japanese Circulation Society, and Japanese Association of Cardiovascular Intervention and Therapeutics, 2nd edition, 2023 chrome-extension. https:\/\/pfo-council.jp\/docs\/publications\/guidance_02_240328.pdf (in Japanese) (accessed April 16, 2025)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med<\/i> 2019; 380: 1906\u20131917.","DOI":"10.1056\/NEJMoa1813959"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Toyoda K, Uchiyama S, Hagihara Y, Kuwashiro T, Mori T, Kamiyama K, et al. Dabigatran vs. Aspirin for secondary prevention after embolic stroke of undetermined source: Japanese subanalysis of the RE-SPECT ESUS randomized controlled trial. Circ J<\/i> 2020; 84: 2286\u20132295.","DOI":"10.1253\/circj.CJ-20-0563"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-25-0115\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:18:18Z","timestamp":1766805498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-25-0115\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0115","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"article-number":"CJ-25-0115"}}